CD8A and neoplasm: Additionally, we observed a trend toward an increase in the proportion of CD45.2+CD8+ T cells infiltrating the tumor in the Tex‐term plus CX4945 group compared to the Tex‐term‐only adoptive cellular therapy group (though not statistically significant) (Figure S4G,H, Supporting Information).